| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.8M | +17.3% |
| R&D Expense | $86.4M | +30.9% |
| SG&A Expense | $33.9M | +17.0% |
| Operating Income | -$110.5M | -20.8% |
| Income Tax | $0 | — |
| Net Income | -$109.0M | -22.1% |
| EPS (Basic) | -$0.34 | +5.6% |
| EPS (Diluted) | -$0.34 | +5.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $319.8M | +130.0% |
| Current Assets | $324.6M | +128.4% |
| Total Assets | $343.3M | +114.1% |
| Current Liabilities | $26.6M | +1.2% |
| Long-term Debt | $50.1M | +14.0% |
| Total Liabilities | $96.4M | +8.5% |
| Stockholders' Equity | $246.9M | +245.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$93.1M | -14.6% |
| Capital Expenditures | $738K | +97.3% |
| Investing Cash Flow | -$604K | -66.4% |
| Financing Cash Flow | $274.6M | +258.1% |
| Free Cash Flow | -$93.8M | -15.0% |